Upexi
UPXI · NASDAQ
About UPXI
- Employees
- 59
- Headquarters
- Tampa, Florida
- Listed
- Jun 24, 2021
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Website
- ir.upexi.com
UPXI key statistics
- Market cap
- 77.64M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 3.13M
- Volume
- 1.57M
- Open price
- $0.9127
- High today
- $0.9434
- Low today
- $0.8711
- 52 Week high
- $5.78
- 52 Week low
- $0.54
Upexi (UPXI) at a glance
As of Oct 20, 2026, Upexi (UPXI) shares are priced at $0.8805, giving the company a market cap of 77.64M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.8711 and $0.9434. The current price is 1.1% above the day's low and 6.7% below its high.
Volume so far is 1.57M shares, below the average of 3.13M shares a day.
Over the past year Upexi has ranged from $0.54 to $5.78, and now sits 6% of the way up that range.
Upexi met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q4 FY26 it reported -$0.21 per share against an estimate of -$0.1224.
The average analyst price target is $5.10, 479.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $2.02
- Now
- $0.8805
- High
- $8.40
UPXI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 23.7% on average.
- Q1 FY24: reported -$1.40 per share against an estimate of -$1.84
- Q2 FY24: reported -$2.00 per share against an estimate of -$1.02
- Q3 FY24: reported -$4.00 per share against an estimate of -$2.04
- Q4 FY25: reported -$2.94 per share against an estimate of -$0.051
- Q1 FY26: reported -$1.67 per share against an estimate of -$0.204
- Q2 FY26: reported -$2.94 per share against an estimate of -$0.051
- Q3 FY26: reported -$1.67 per share against an estimate of -$0.204
- Q4 FY26: reported -$0.21 per share against an estimate of -$0.1224
UPXI news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Upexi Reports Financial Results for Fiscal Year Ended June 30, 2026
- Press releaseGlobe Newswire
Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET
- Press releaseGlobe Newswire
Upexi Amends BitGo Credit Facility
- Press releaseGlobe Newswire
Upexi Partners with Blueprint to Stake Solana Treasury Assets
- Press releaseGlobe Newswire
Upexi Added to the Russell Microcap® Index
- Press releaseGlobe Newswire
Upexi Reports Fiscal Third Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19
Similar companies
Companies in the same industry as Upexi
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.